513
Views
16
CrossRef citations to date
0
Altmetric
Clinical Study

Improvement of Renal Function in Type 2 Diabetic Nephropathy

, , &
Pages 155-158 | Published online: 07 Jul 2009

REFERENCES

  • Amos AF, McCarthy DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet. Med. 1997; 14(Suppl. 5)S1–S85
  • Parving HH, Hommel E, Mathiesen E, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br. Med. J. 1988; 296: 156–160
  • Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 1997; 99: 342–348
  • Moriya T, Moriya R, Yajima Y, et al. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron. 2002; 91: 292–299
  • Risdon FC, Sloper SA, de Wardener HE. Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968; 2: 363–366
  • Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999; 33: 886–891
  • Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 2002; 13: 806–816
  • Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A, Watanapenphaibul K, et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren. Fail. 2000; 22: 329–335
  • Fine LG, Ong ACM, Norman JT. Mechanism of tubulointerstitial injury in progressive renal disease. Eur. J. Clin. Invest. 1993; 25: 259–265
  • Butthep P, Nuchprayoon I, Futrakul N. Endothelial injury and altered hemodynamics in Thalassemia. Clin. Hemorheol. Microcirc. 2004; 31: 287–293
  • Futrakul N, Sitprija V, Siriviriyakul P, Futrakul P. Glomerular endothelial dysfunction, altered hemorheology and hemodynamic maladjustment in nephrosis with focal segmental glomerulosclerosis. Hong Kong J. Nephrol. 2004; 6: 69–73
  • Futrakul N, Laohaphaibul A, Futrakul P. Glomerular endothelial dysfunction and hemodynamic maladjustment in vesicoureteric reflux. Ren. Fail. 2003; 25: 479–483
  • Futrakul P, Pochanugool C, Poshyachinda M, et al. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators. J. Med. Assoc. Thai. 1992; 75: 375–385
  • Pisoni R, Faraone R, Ruggenenti P, Remuzzi G. Inhibitors of the rennin angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency. J. Neprhol. 2002; 15: 428–430
  • Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR. J. Am. Soc. Nephrol. 1999; 10: 997–1006
  • Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetes rats. J. Am. Soc. Nephrol. 2005; 16: 703–711
  • Hilgers K. Never too early to treat type 2 DN. J. Am. Soc. Nephrol. 2005; 16: 574–575

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.